Common menu bar links
Related Information
Institutes & Programs
- NRC Biotechnology Research Institute
- NRC Canadian Neutron Beam Centre
- NRC Canadian Photonics Fabrication Centre
- NRC Genomics and Health Initiative
- NRC Imaging Network Portal
- NRC Institute for Biodiagnostics
- NRC Institute for Biological Sciences
- NRC Institute for Marine Biosciences
- NRC Institute for Microstructural Sciences
- NRC Institute for Nutrisciences and Health
- NRC Plant Biotechnology Institute
- National Institute for Nanotechnology
- National Research Council Canada
Key Sectors
Areas of Research
Communities
Careers
News
Events
Enquiries: NRC-GHI
Fax: 613-947-3067
Email: ghi.info@nrc.gc.ca
100 Sussex Drive
Ottawa,
Ontario,
K1A 0R6
Canada
Heart Disease: Better Tools for Better Treatment
Building upon successful innovations in NRC-GHI Phase 3, this continuing program aims to further develop and test new diagnostic and imaging tools that will improve the treatment and management of heart disease. In particular, this program proposes to expand technologies that will allow health-care professionals to treat patients earlier and more efficiently by providing a series of methods that will help triage patients with evolving heart attacks, offer tools for improved planning and guidance of minimally invasive heart surgery, and help predict patient outcomes. With the final goal of bringing such technologies into clinical practice, this program will benefit Canadians through improved cardiovascular disease diagnosis and better surgical outcomes, as well as a more efficient health-care system. The Canadian economy may also benefit from a stronger medical devices industry, with increased jobs and enhanced national revenue.
Research SuccessNRC and IMRIS Inc., a Canadian surgical imaging company, are collaborating within this NRC-GHI research project to develop MRI radiofrequency coils that will provide clearer and more detailed images of cardiac function and coronary vessels than systems currently available on the market. IMRIS will integrate this technology into their upcoming product line to be sold world-wide. Commercialization of this technology supports the creation of a new cardiac imaging business division within IMRIS, enabling this Canadian company to exploit the increasing importance of MRI in cardiac surgery and interventional cardiology. |
